The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 5 , Pages 1150-1156 , November 2007

Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis

  • Bertrand Marcheix, MD, MSc

      Affiliations

    • Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Yoan Lamarche, MD, MSc

      Affiliations

    • Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Colin Berry, MD, PhD

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • Dr Berry was supported by a British Heart Foundation International Fellowship.
    • ,
  • Anita Asgar, MD

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Jean-Claude Laborde, MD

      Affiliations

    • Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France
    • Drs Bonan and Laborde are consultants to CoreValve, Inc, Paris, France.
    • ,
  • Arsène Basmadjian, MD, MSc

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Anique Ducharme, MD, MSc

      Affiliations

    • Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada.
    • ,
  • André Denault, MD

      Affiliations

    • Department of Anesthesiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • ,
  • Raoul Bonan, MD

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • Drs Bonan and Laborde are consultants to CoreValve, Inc, Paris, France.
    • ,
  • Raymond Cartier, MD

      Affiliations

    • Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • Corresponding Author InformationAddress for reprints: Raymond Cartier, MD, Department of Cardiovascular Surgery, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada.

Received 9 February 2007 ,Revised 3 July 2007 ,Accepted 10 July 2007.

  • Image Result

    CoreValve percutaneous aortic prosthesis (A). Perioperative x-ray imaging demonstrating 23-mm balloon dilatation of the stenotic aortic valve (B). Retrograde delivery catheter advancement toward the a

    CoreValve percutaneous aortic prosthesis (A). Perioperative x-ray imaging demonstrating 23-mm balloon dilatation of the stenotic aortic valve (B). Retrograde delivery catheter advancement toward the aortic arch and deployment of the prosthesis (C–E). A perioperative angiogram demonstrated excellent position and function of the bioprosthesis. The left and right coronary ostia are patent. There is no evidence of intraprosthetic or periprosthetic insufficiency (F).

  • Image Result
    Improvements in the aortic valve (AV) area (A) and mean transaortic gradient after endovascular AVR (B). Aortic valve regurgitation remained mild (≤ grade 2, and ≤ grade 1 in most) immediately after A

    Improvements in the aortic valve (AV) area (A) and mean transaortic gradient after endovascular AVR (B). Aortic valve regurgitation remained mild (≤ grade 2, and ≤ grade 1 in most) immediately after AVR and during follow-up (C). Improvement in New York Heart Association (NYHA) functional class (D). Each curve represents the data for 1 patient. PAVR, Percutaneous aortic valve replacement; AI, aortic insufficiency; SD, standard deviation.

PII: S0022-5223(07)01300-1

doi: 10.1016/j.jtcvs.2007.07.031

The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 5 , Pages 1150-1156 , November 2007

Article Tools

* Image Usage & Resolution